InvestorsHub Logo
Followers 23
Posts 1033
Boards Moderated 0
Alias Born 05/22/2014

Re: concordia post# 52713

Friday, 09/23/2016 8:08:53 PM

Friday, September 23, 2016 8:08:53 PM

Post# of 144813
"Much has been made of the shortage of scientific expertise at the chief executive officer (CEO) level in
today’s pharma industry. Our analysis of CEOs of the top pharmaceutical companies endorses this view and
demonstrates a clear lack of scientific backgrounds and specific pharmaceutical industry R&D experience.
Among the top global pharma companies [Ref 9], more than 70% of CEO seats are held by non-scientists*
(Diagram 1), and 80% have had no industry-specific R&D experience (Diagram 2)." - Page 7
http://www.russellreynolds.com/en/Insights/thought-leadership/Documents/Enhancing%20Scientific%20Acumen%20in%20the%20Pharma%20Boardroom_RRA_2015.pdf

I am very comfortable with the job Mr. Waggoner is doing. We will get there, one step at a time. Long. Go PMCB!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News